Senators seek answers from FDA in dietary supplements fraud inquiry
Senate Special Committee on Aging Sens. Claire McCaskill (D-Mo.) and Susan Collins (R-Me.) are demanding FDA send them a lot of information in a short amount of time – by July 13 – about how the agency exercises its regulatory authority to prevent adulterated, mislabeled and fraudulent dietary supplements from getting on the market.